临床肿瘤学杂志

• 论著 • 上一篇    下一篇

基于EUD鼻咽癌调强放疗中NTCP和TCP的计算程序设计研究

鹿红1,李兵2,宋威1,于大海1,赵迪1,张碧云1   

  1. 1 210029 南京 江苏省中医院放疗科 2 210002南京军区南京总医院放疗科
  • 收稿日期:2016-10-31 修回日期:2017-01-12 出版日期:2017-04-30 发布日期:2017-04-30
  • 通讯作者: 李兵

Design of normal tissue complication probability(NTCP)and tumor control probability(TCP)calculation program for intensity modulated radiotherapy for nasopharyngeal carcinoma based on EUD

LU Hong,LI Bing,SONG Wei,YU Dahai,ZHAO Di,ZHANG Biyun   

  1. Department of Radiotherapy,Jiangsu Hospital of Traditional Chinese Medicine,Nanjing 210029,China
  • Received:2016-10-31 Revised:2017-01-12 Online:2017-04-30 Published:2017-04-30
  • Contact: LI Bing

摘要:

目的 设计一个基于等效均一剂量(EUD)的计算程序来计算鼻咽癌调强放疗(IMRT)计划中正常组织并发症概率(NTCP)和肿瘤控制概率(TCP)。方法 采用具有较强数学特性及友好交互界面等优势的高效编程语言Matlab编写计算NTCP和TCP程序,其中NTCP 数学模型选用基于EUD的LymanKutcherBurman模型,而TCP模型则选用Schultheiss逻辑模型 。收集3例接受IMRT治疗的鼻咽癌患者的正常组织和靶区剂量体积直方图(DVH),计划系统为医科达precise plan。结果编写计算机代码保存为Matlab可执行程序。3例鼻咽癌患者的4种正常组织(脑干、脊髓、左右侧腮腺)和肿瘤的EUD被编写程序算出,进而计算出NTCP和TCP。结论 编写的程序对正常组织耐受量的计算结果与理论值非常吻合,有助于临床选择更安全和高效的治疗方案,将来还可将程序用于其他肿瘤如前列腺癌和肺癌的放疗计划中。

Abstract:

Objective To calculate the normal tissue complication probability(NTCP)and the tumor control probability(TCP)of intensity modulated radiotherapy(IMRT)plan for nasopharyngeal carcinoma(NPC)by using an equivalent uniform dose(EUD). Methods As a high-level technical computing language with friendly interface and mathematical properties,Matlab was chosen to implement the EUD-based Lyman-Kutcher-Burman NTCP mathematical model and Schultheiss TCP logistic model. The normal tissue and target dose-volume histogram(DVH)of three patients with NPC were obtained from Elekta precise treatment planning system. The necessary parameters for the model were clearly defined. Results The computer code is presented and saved as a Matlab program. The EUD and NTCP values of four normal tissues from three NPC patients were generated and the TCP values were further gained. Conclusion The model has an excellent ability in fitting the normal structures tolerance values in this study. It is helpful for clinicians to select safer and more effective treatment plans. In future,the program will be modified and tested in radiotherapy for prostate and lung cancer.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!